Evidence map›Paper›PMID 41385310›Full record

ArticleBioinformatics (Oxford, England)2026

Causal knowledge graph analysis identifies adverse drug effects.

Sumyyah Toonsi, Paul N Schofield, Robert Hoehndorf

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Causal graph neural networks for healthcare.Nature biomedical engineering · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sumyyah ToonsiComputer, Electrical and Mathematical Sciences & Engineering Division, King Abdullah University of Science and Technology, Thuwal 23955, Saudi Arabia.ORCID 0000-0003-4746-4649
Paul N SchofieldDepartment of Physiology, Development & Neuroscience, University of Cambridge, Cambridge, CB2 3EG, United Kingdom.ORCID 0000-0002-5111-7263
Robert HoehndorfComputer, Electrical and Mathematical Sciences & Engineering Division, King Abdullah University of Science and Technology, Thuwal 23955, Saudi Arabia.ORCID 0000-0001-8149-5890

Funding

King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research FCC/1/5932-11-01King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research FCC/1/5932-12-10King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research REI/1/4938-01-01King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research REI/1/5659-01-01King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research REP/1/6338-01-01King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research URF/1/5041-01-01, FCC/1/5932-10-02
6 · The paper itself

Abstract

motivationKnowledge graphs and structural causal models have each proven valuable for organizing biomedical knowledge and estimating causal effects, but remain largely disconnected: knowledge graphs encode qualitative relationships focusing on facts and deductive reasoning without formal probabilistic semantics, while causal models lack integration with background knowledge in knowledge graphs and have no access to the deductive reasoning capabilities that knowledge graphs provide.

resultsTo bridge this gap, we introduce a novel formulation of Causal Knowledge Graphs (CKGs) which extend knowledge graphs with formal causal semantics, preserving their deductive capabilities while enabling principled causal inference. CKGs support deconfounding via explicitly marked causal edges and facilitate hypothesis formulation aligned with both encoded and entailed background knowledge. We constructed a Drug-Disease CKG (DD-CKG) integrating disease progression pathways, drug indications, side-effects, and hierarchical disease classification to enable automated large-scale mediation analysis. Applied to UK Biobank and MIMIC-IV cohorts, we tested whether drugs mediate effects between indications and downstream disease progression, adjusting for confounders inferred from the DD-CKG. Our approach successfully reproduced known adverse drug reactions with high precision while identifying previously undocumented significant candidate adverse effects. Further validation through side effect similarity analysis demonstrated that combining our predicted drug effects with established databases significantly improves the prediction of shared drug indications, supporting the clinical relevance of our novel findings. These results demonstrate that our methodology provides a generalizable, knowledge-driven framework for scalable causal inference. AVAILABILITY AND IMPLEMENTATION: The data is available through https://github.com/bio-ontology-research-group/Mediation-Analysis-using-Causal-Knowledge-Graph.

Indexed as

Computational BiologyDrug-Related Side Effects and Adverse ReactionsAlgorithmsHumans

Identifiers

PMID41385310
PMCPMC12790815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.